O

Origene

Empower your research

Rockville, United States · Founded 1996 · $54.3M raised

Employees
201–500
Founded
1996
Business Model
B2B
Total Funding
$54.3M
Last Round
$17.0M Venture RoundJul 2015
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

OriGene Technologies was founded as a research tool company focused on creating the largest commercial collection of full-length human cDNAs in a standard expression vector. Its flagship product is a searchable gene bank of over 30,000 human full-length TrueClone cDNA collections and over 25,000 TrueORF cDNA clones, from which it has developed the largest offering of full-length human proteins expressed in mammalian cells for functional studies. OriGene uses a high-throughput, genome-wide approach to develop products for pharmaceutical, biotechnology, and academic research, including TrueMAB mouse monoclonal antibodies and TissueScan cancer tissue qPCR arrays, with a mission to be "Your Gene Company" supplying everything researchers need for gene-based research.

Summary

Origene is a Biotech company based in Rockville, United States, founded in 1996. It has raised $54.3M in total across 3 rounds, most recently a $17.0M Venture Round in Jul 2015. Investors include IDG-Accel, Qiming VP and Morningside Venture Investments.

Funding History

Venture RoundVenture RoundJul 2015
$17.0M

Sign up to see all 3 events

Funding: Series C through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Origene on Indexed.vc
<a href="https://indexed.vc/companies/origene"><img src="https://indexed.vc/api/badge/company/origene" alt="Origene on Indexed.vc" width="260" height="76" /></a>